Glenmark Pharma Q2 Results | Drug firm returns to profit, revenue up 7%

Glenmark Pharma Q2 Results | The company posted a net profit of ₹354.4 crore. EBITDA surged 30.2% to ₹601.7 crore over ₹462 crore in the year-ago period. Shares of Glenmark Pharmaceuticals Ltd ended at ₹1,539, up by ₹0.50, or 0.032%, on the BSE.